Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

ACHIEVE LIFE SCIENCES, INC. (ACHV)

$6.10 -1.13% NASDAQ: ACHV · 15-min delayed
  • SEATTLE, Washington
  • Public · NASDAQ: ACHV
  • 28 employees
$526.6MMarket cap
$0Revenue · FY2019
-$54.6MNet income
28Employees
ACHVNASDAQ
1995IPO

About ACHIEVE LIFE SCIENCES, INC.

Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Revenue FY2019
$0
Net income
-$54.6M
Total assets
$41.8M
Market cap
$526.6M

Source: SEC EDGAR · updated Jun 7, 2026

Multi-year

Revenue & profit trend

Revenue Net income
FY 2025

Financial statements

Income statement

Net income
-$54.6M
EPS (basic)
$-1.25
EPS (diluted)
$-1.25

Balance sheet

Total assets
$41.8M
Current assets
$39.9M
Total liabilities
$20.3M
Current liabilities
$9.1M
Shareholders’ equity
$21.5M

Cash flow

Operating cash flow
-$49.5M
Investing cash flow
$6.1M
Financing cash flow
$51.5M
Net cash flow
$8.2M

Statements via Polygon.io (SEC filings)

NASDAQ: ACHV
$6.10 -1.13%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$2.07 $6.53

52-week range

Market cap
$526.6M
EPS (diluted)
$-1.25
Shares outstanding
86.3M
Open
Day range
Prev close
Volume
IPO date
Oct 12, 1995

Achieve Life Sciences, Inc. (ACHV) Stock Price

  • Reported a net loss of $54.6M in FY2019.
  • Trading 7% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review ACHIEVE LIFE SCIENCES, INC..

Write a review
Newsroom

News about ACHIEVE LIFE SCIENCES, INC.

News & sentiment via Polygon.io

FAQ

Achieve Life Sciences, Inc.: frequently asked questions

Is Achieve Life Sciences, Inc. an American company?

Achieve Life Sciences, Inc. is a US-based company headquartered in Seattle, Washington, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Achieve Life Sciences, Inc. headquartered?

Achieve Life Sciences, Inc. is headquartered in Seattle, Washington, United States.

Is Achieve Life Sciences, Inc. publicly traded?

Yes — Achieve Life Sciences, Inc. is a publicly traded company. Its stock trades under the ticker symbol ACHV on the NASDAQ.

What does Achieve Life Sciences, Inc. do?

Achieve Life Sciences, Inc. is an American Medical Devices company in the Health & Beauty sector.

Explore

Similar companies

Browse all →